Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Steven Dubinett
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Chemicals & Drugs
Living Beings
Anatomy
Sign-in to see full Profile
Network (preview)
75
Sharma, Sherven
32
Huang, Min
27
Batra, Raj
26
Dohadwala, Mariam
22
Zhu, Li
22
Strieter, Robert
21
Krysan, Kostyantyn
18
Mao, Jenny
16
Luo, Jie
16
Gardner, Brian
15
Yang, Seok-Chul
13
Zhu, Li
13
Reckamp, Karen
12
Roth, Michael
12
Stolina, Marina
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Steven Dubinett (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Yanagawa Jane; Walser Tonya C; Zhu Li X; Hong Longsheng; Fishbein Michael C; Mah Vei; Chia David; Goodglick Lee; Elashoff David A; Luo Jie; Magyar Clara E; Dohadwala Mariam; Lee Jay M; St John Maie A; Strieter Robert M; Sharma Sherven; Dubinett Steven M
Snail promotes CXCR2 ligand-dependent tumor progression in non-small cell lung carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(22):6820-9.
-
2009: Garon Edward B; Dubinett Steven M
Intracellular signaling molecules.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(11 Suppl 3):S1057-8.
-
2009: St John Maie A; Dohadwala Mariam; Luo Jie; Wang Guanyu; Lee Gina; Shih Hubert; Heinrich Eileen; Krysan Kostantyn; Walser Tonya; Hazra Saswati; Zhu Li; Lai Chi; Abemayor Elliot; Fishbein Michael; Elashoff David A; Sharma Sherven; Dubinett Steven M
Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(19):6018-27.
-
2009: Limsukon Atikun; Susanto Irawan; Hoo Guy W Soo; Dubinett Steven M; Batra Raj K
Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy.
Chest 2009;136(3):924-6.
-
2009: Lee Gina; Walser Tonya C; Dubinett Steven M
Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer.
Current opinion in pulmonary medicine 2009;15(4):303-7.
-
2009: Andersson Asa; Yang Seok-Chul; Huang Min; Zhu Li; Kar Upendra K; Batra Raj K; Elashoff David; Strieter Robert M; Dubinett Steven M; Sharma Sherven
IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(11):6951-8.
-
2009: Punturieri Antonello; Szabo Eva; Croxton Thomas L; Shapiro Steven D; Dubinett Steven M
Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research.
Journal of the National Cancer Institute 2009;101(8):554-9.
-
2009: Lu Qing-Yi; Yang Yanan; Jin Yu Sheng; Zhang Zuo-Feng; Heber David; Li Frederick P; Dubinett Steven M; Sondej Melissa A; Loo Joseph A; Rao Jian Yu
Effects of green tea extract on lung cancer A549 cells: proteomic identification of proteins associated with cell migration.
Proteomics 2009;9(3):757-67.
-
2009: Reckamp Karen L; Figlin Robert A; Burdick Marie D; Dubinett Steven M; Elashoff Robert M; Strieter Robert M
CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer.
BMC cancer 2009;9():213.
-
2008: Walser Tonya; Cui Xiaoyan; Yanagawa Jane; Lee Jay M; Heinrich Eileen; Lee Gina; Sharma Sherven; Dubinett Steven M
Smoking and lung cancer: the role of inflammation.
Proceedings of the American Thoracic Society 2008;5(8):811-5.
-
2008: Dubinett Steven M; Aberle Denise R; Tashkin Donald P; Mao Jenny T
The partners--airflow obstruction, emphysema, and lung cancer.
American journal of respiratory and critical care medicine 2008;178(7):665-6.
-
2008: Dubinett Steven M; Mao Jenny T; Hazra Saswati
Focusing downstream in lung cancer prevention: 15-hydroxyprostaglandin dehydrogenase.
Cancer prevention research (Philadelphia, Pa.) 2008;1(4):223-5.
-
2008: Lee Jay M; Yanagawa Jane; Peebles Katherine A; Sharma Sherven; Mao Jenny T; Dubinett Steven M
Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment.
Critical reviews in oncology/hematology 2008;66(3):208-17.
-
2008: Su Helen; Seimbille Yann; Ferl Gregory Z; Bodenstein Claudia; Fueger Barbara; Kim Kevin J; Hsu Yu-Tien; Dubinett Steven M; Phelps Michael E; Czernin Johannes; Weber Wolfgang A
Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.
European journal of nuclear medicine and molecular imaging 2008;35(6):1089-99.
-
2008: Einhorn Lawrence H; Bonomi Philip; Bunn Paul A; Camidge D Ross; Carbone David Paul; Choy Hak; Dubinett Steven M; Gandara David R; Gaspar Laurie E; Govindan Ramaswamy; Johnson David H; Minna John D; Scagliotti Giorgio; West Howard J; Herbst Roy S
Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(5):545-55.
-
2008: Reckamp Karen L; Gardner Brian K; Figlin Robert A; Elashoff David; Krysan Kostyantyn; Dohadwala Mariam; Mao Jenny; Sharma Sherven; Inge Landon; Rajasekaran Ayyappan; Dubinett Steven M
Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(2):117-24.
-
2008: Krysan Kostyantyn; Lee Jay M; Dohadwala Mariam; Gardner Brian K; Reckamp Karen L; Garon Edward; St John Maie; Sharma Sherven; Dubinett Steven M
Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistance.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2008;3(2):107-10.
-
2008: Hazra Saswati; Peebles Katherine A; Sharma Sherven; Mao Jenny T; Dubinett Steven M
The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.
PPAR research 2008;2008():790568.
-
2008: Baratelli Felicita; Takedatsu Hiroko; Hazra Saswati; Peebles Katherine; Luo Jie; Kurimoto Pam S; Zeng Gang; Batra Raj K; Sharma Sherven; Dubinett Steven M; Lee Jay M
Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer.
Journal of translational medicine 2008;6():38.
-
2007: Liu Ming; Yang Seok-Chul; Sharma Sherven; Luo Jie; Cui Xiaoyan; Peebles Katherine A; Huang Min; Sato Mitsuo; Ramirez Ruben D; Shay Jerry W; Minna John D; Dubinett Steven M
EGFR signaling is required for TGF-beta 1 mediated COX-2 induction in human bronchial epithelial cells.
American journal of respiratory cell and molecular biology 2007;37(5):578-88.
-
2007: Peebles Katherine A; Lee Jay M; Mao Jenny T; Hazra Saswati; Reckamp Karen L; Krysan Kostyantyn; Dohadwala Mariam; Heinrich Eileen L; Walser Tonya C; Cui Xiaoyan; Baratelli Felicita E; Garon Edward; Sharma Sherven; Dubinett Steven M
Inflammation and lung carcinogenesis: applying findings in prevention and treatment.
Expert review of anticancer therapy 2007;7(10):1405-21.
-
2007: Hazra Saswati; Dubinett Steven M
Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.
Prostaglandins, leukotrienes, and essential fatty acids 2007;77(1):51-8.
-
2007: Hazra Saswati; Batra Raj K; Tai Hsin H; Sharma Sherven; Cui Xiaoyan; Dubinett Steven M
Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.
Molecular pharmacology 2007;71(6):1715-20.
-
2007: Cui X; Zhang L; Luo J; Rajasekaran A; Hazra S; Cacalano N; Dubinett S M
Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer.
Oncogene 2007;26(29):4253-60.
-
2007: Lu Qing-Yi; Jin Yu Sheng; Zhang Zuo-Feng; Le Anh D; Heber David; Li Frederick P; Dubinett Steven M; Rao Jian Yu
Green tea induces annexin-I expression in human lung adenocarcinoma A549 cells: involvement of annexin-I in actin remodeling.
Laboratory investigation; a journal of technical methods and pathology 2007;87(5):456-65.
-
2007: Lee Jay M; Mao Jenny T; Krysan Kostyantyn; Dubinett Steven M
Significance of cyclooxygenase-2 in prognosis, targeted therapy and chemoprevention of NSCLC.
Future oncology (London, England) 2007;3(2):149-53.
-
2006: Su Helen; Bodenstein Claudia; Dumont Rebecca A; Seimbille Yann; Dubinett Steven; Phelps Michael E; Herschman Harvey; Czernin Johannes; Weber Wolfgang
Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(19):5659-67.
-
2006: Feeley Brian T; Liu Nancy Q; Conduah Augustine H; Krenek Lucie; Roth Kevin; Dougall William C; Huard Johnny; Dubinett Steve; Lieberman Jay R
Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006;21(10):1571-80.
-
2006: Zeng Gang; Aldridge Michael E; Tian Xiaoli; Seiler Daniel; Zhang Xiaolong; Jin Yusheng; Rao Jianyu; Li Weidong; Chen Dequan; Langford Marlyn P; Duggan Chris; Belldegrun Arie S; Dubinett Steven M
Dendritic cell surface calreticulin is a receptor for NY-ESO-1: direct interactions between tumor-associated antigen and the innate immune system.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(6):3582-9.
-
2006: Reckamp Karen L; Krysan Kostyantyn; Morrow Jason D; Milne Ginger L; Newman Robert A; Tucker Christopher; Elashoff Robert M; Dubinett Steven M; Figlin Robert A
A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 1):3381-8.
-
2006: Hoang Bao; Zhu Li; Shi Yijiang; Frost Patrick; Yan Huajun; Sharma Sanjai; Sharma Sherven; Goodglick Lee; Dubinett Steven; Lichtenstein Alan
Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance.
Blood 2006;107(11):4484-90.
-
2006: Krysan Kostyantyn; Reckamp Karen L; Sharma Sherven; Dubinett Steven M
The potential and rationale for COX-2 inhibitors in lung cancer.
Anti-cancer agents in medicinal chemistry 2006;6(3):209-20.
-
2006: Dohadwala Mariam; Yang Seok-Chul; Luo Jie; Sharma Sherven; Batra Raj K; Huang Min; Lin Ying; Goodglick Lee; Krysan Kostyantyn; Fishbein Michael C; Hong Longsheng; Lai Chi; Cameron Robert B; Gemmill Robert M; Drabkin Harry A; Dubinett Steven M
Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.
Cancer research 2006;66(10):5338-45.
-
2006: Cui Xiaoyan; Yang Seok-Chul; Sharma Sherven; Heuze-Vourc'h Nathalie; Dubinett Steven M
IL-4 regulates COX-2 and PGE2 production in human non-small cell lung cancer.
Biochemical and biophysical research communications 2006;343(4):995-1001.
-
2006: Yang Seok-Chul; Batra Raj K; Hillinger Sven; Reckamp Karen L; Strieter Robert M; Dubinett Steven M; Sharma Sherven
Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
Cancer research 2006;66(6):3205-13.
-
2006: Pan Judong; Burdick Marie D; Belperio John A; Xue Ying Ying; Gerard Craig; Sharma Sherven; Dubinett Steven M; Strieter Robert M
CXCR3/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(3):1456-64.
-
2006: Liu Wei; Dubinett Steven; Patterson Simie Lavern A; Kelly Kathleen A
COX-2 inhibition affects growth rate of Chlamydia muridarum within epithelial cells.
Microbes and infection / Institut Pasteur 2006;8(2):478-86.
-
2006: Mao Jenny T; Fishbein Michael C; Adams Bradley; Roth Michael D; Goodglick Lee; Hong Longsheng; Burdick Marie; Strieter E Robert M; Holmes Carmack; Tashkin Donald P; Dubinett Steven M
Celecoxib decreases Ki-67 proliferative index in active smokers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(1):314-20.
-
2006: Zhang L; Sharma S; Hershman J M; Brent G A; Dubinett S M; Huang M
Iodide sensitizes genetically modified non-small cell lung cancer cells to ionizing radiation.
Cancer gene therapy 2006;13(1):74-81.
-
2005: Weinberg Olga K; Marquez-Garban Diana C; Fishbein Michael C; Goodglick Lee; Garban Hermes J; Dubinett Steven M; Pietras Richard J
Aromatase inhibitors in human lung cancer therapy.
Cancer research 2005;65(24):11287-91.
-
2005: Dalwadi Harnisha; Krysan Kostyantyn; Heuze-Vourc'h Nathalie; Dohadwala Mariam; Elashoff David; Sharma Sherven; Cacalano Nicholas; Lichtenstein Alan; Dubinett Steven
Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7674-82.
-
2005: Rodriguez Paulo C; Hernandez Claudia P; Quiceno David; Dubinett Steven M; Zabaleta Jovanny; Ochoa Juan B; Gilbert Jill; Ochoa Augusto C
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma.
The Journal of experimental medicine 2005;202(7):931-9.
-
2005: Baratelli Felicita; Lin Ying; Zhu Li; Yang Seok-Chul; Heuzé-Vourc'h Nathalie; Zeng Gang; Reckamp Karen; Dohadwala Mariam; Sharma Sherven; Dubinett Steven M
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(3):1483-90.
-
2005: Baratelli Felicita; Krysan Kostyantyn; Heuzé-Vourc'h Nathalie; Zhu Li; Escuadro Brian; Sharma Sherven; Reckamp Karen; Dohadwala Mariam; Dubinett Steven M
PGE2 confers survivin-dependent apoptosis resistance in human monocyte-derived dendritic cells.
Journal of leukocyte biology 2005;78(2):555-64.
-
2005: Mao Jenny T; Cui Xiaoyan; Reckamp Karen; Liu Ming; Krysan Kostyantyn; Dalwadi Harnisha; Sharma Sherven; Hazra Saswati; Strieter Robert; Gardner Brian; Dubinett Steven M
Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer.
Clinical lung cancer 2005;7(1):30-9.
-
2005: Krysan Kostyantyn; Reckamp Karen L; Dalwadi Harnisha; Sharma Sherven; Rozengurt Enrique; Dohadwala Mariam; Dubinett Steven M
Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
Cancer research 2005;65(14):6275-81.
-
2005: Sharma Sherven; Zhu Li; Yang Seok Chul; Zhang Ling; Lin Jeff; Hillinger Sven; Gardner Brian; Reckamp Karen; Strieter Robert M; Huang Min; Batra Raj K; Dubinett Steven M
Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responses.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(2):813-9.
-
2005: Heuzé-Vourc'h Nathalie; Liu Ming; Dalwadi Harnisha; Baratelli Felicita E; Zhu Li; Goodglick Lee; Põld Mehis; Sharma Sherven; Ramirez Ruben D; Shay Jerry W; Minna John D; Strieter Robert M; Dubinett Steven M
IL-20, an anti-angiogenic cytokine that inhibits COX-2 expression.
Biochemical and biophysical research communications 2005;333(2):470-5.
-
2005: Sharma Sherven; Yang Seok-Chul; Zhu Li; Reckamp Karen; Gardner Brian; Baratelli Felicita; Huang Min; Batra Raj K; Dubinett Steven M
Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer.
Cancer research 2005;65(12):5211-20.
-
2005: Zeng Gang; Aldridge Michael E; Wang Yu; Pantuck Allan J; Wang Allen Y; Liu Yue-xiang; Han Yan; Yuan Yan-hua; Robbins Paul F; Dubinett Steven M; deKernion Jean B; Belldegrun Arie S
Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker.
International journal of cancer. Journal international du cancer 2005;114(2):268-73.
-
2005: Gamradt Seth C; Feeley Brian T; Liu Nancy Q; Roostaeian Jason; Lin Ying Q; Zhu Li X; Sharma Sherven; Dubinett Steven M; Lieberman Jay R
The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone.
Anticancer research 2005;25(1A):107-15.
-
2004: Strieter Robert M; Belperio John A; Burdick Marie D; Sharma Sherven; Dubinett Steven M; Keane Michael P
CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer.
Annals of the New York Academy of Sciences 2004;1028():351-60.
-
2004: Baratelli Felicita E; Heuzé-Vourc'h Nathalie; Krysan Kostyantyn; Dohadwala Mariam; Riedl Karen; Sharma Sherven; Dubinett Steven M
Prostaglandin E2-dependent enhancement of tissue inhibitors of metalloproteinases-1 production limits dendritic cell migration through extracellular matrix.
Journal of immunology (Baltimore, Md. : 1950) 2004;173(9):5458-66.
-
2004: Mao Jenny T; Tsu I-Hsien; Dubinett Steven M; Adams Bradley; Sarafian Theodore; Baratelli Felicita; Roth Michael D; Serio Kenneth J
Modulation of pulmonary leukotriene B4 production by cyclooxygenase-2 inhibitors and lipopolysaccharide.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):6872-8.
-
2004: Põld Mehis; Krysan Kostyantyn; Põld Anu; Dohadwala Mariam; Heuze-Vourc'h Nathalie; Mao Jenny T; Riedl Karen L; Sharma Sherven; Dubinett Steven M
Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancer.
Cancer research 2004;64(18):6549-55.
-
2004: Krysan Kostyantyn; Dalwadi Harnisha; Sharma Sherven; Põld Mehis; Dubinett Steven
Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer.
Cancer research 2004;64(18):6359-62.
-
2004: Dubinett Steven M; Elashoff David; Meyerson Matthew
Assessing prognosis in non-small-cell lung cancer: avenues to a more complete picture?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(16):3209-11.
-
2004: Zhang Ling; Keane Michael P; Zhu Li X; Sharma Sherven; Rozengurt Enrique; Strieter Robert M; Dubinett Steven M; Huang Min
Interleukin-7 and transforming growth factor-beta play counter-regulatory roles in protein kinase C-delta-dependent control of fibroblast collagen synthesis in pulmonary fibrosis.
The Journal of biological chemistry 2004;279(27):28315-9.
-
2004: Riedl Karen; Krysan Kostyantyn; Põld Mehis; Dalwadi Harnisha; Heuze-Vourc'h Nathalie; Dohadwala Mariam; Liu Ming; Cui Xiaoyan; Figlin Robert; Mao Jenny T; Strieter Robert; Sharma Sherven; Dubinett Steven M
Multifaceted roles of cyclooxygenase-2 in lung cancer.
Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 2004;7(3):169-84.
-
2004: Krysan Kostyantyn; Dohadwala Mariam; Luo Jie; Lin Ying; Zhu Li; Heuze-Vourc'h Nathalie; Goodglick Lee; Merchant Farrukh; Seligson David; Pold Mehis; Strieter Robert; Sharma Sherven; Dubinett Steven
Cyclooxygenase-2-dependent expression of survivin in non-small cell lung cancer.
Chest 2004;125(5 Suppl):140S.
-
2004: Sandler Alan B; Dubinett Steven M
COX-2 inhibition and lung cancer.
Seminars in oncology 2004;31(2 Suppl 7):45-52.
-
2004: Yang Seok-Chul; Hillinger Sven; Riedl Karen; Zhang Ling; Zhu Li; Huang Min; Atianzar Kimberly; Kuo Brian Y; Gardner Brian; Batra Raj K; Strieter Robert M; Dubinett Steven M; Sharma Sherven
Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(8):2891-901.
-
2004: Põld Mehis; Zhu Li X; Sharma Sherven; Burdick Marie D; Lin Ying; Lee Peter P N; Põld Anu; Luo Jie; Krysan Kostyantyn; Dohadwala Mariam; Mao Jenny T; Batra Raj K; Strieter Robert M; Dubinett Steven M
Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer.
Cancer research 2004;64(5):1853-60.
-
2004: Gardner Brian; Zhu Li X; Roth Michael D; Tashkin Donald P; Dubinett Steven M; Sharma Sherven
Cocaine modulates cytokine and enhances tumor growth through sigma receptors.
Journal of neuroimmunology 2004;147(1-2):95-8.
-
2004: Krysan Kostyantyn; Merchant Farrukh H; Zhu Li; Dohadwala Mariam; Luo Jie; Lin Ying; Heuze-Vourc'h Nathalie; Põld Mehis; Seligson David; Chia David; Goodglick Lee; Wang Hejing; Strieter Robert; Sharma Sherven; Dubinett Steven
COX-2-dependent stabilization of survivin in non-small cell lung cancer.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(1):206-8.
-
2003: Mao Jenny T; Roth Michael D; Serio Kenneth J; Baratelli Felicita; Zhu Li; Holmes E Carmack; Strieter Robert M; Dubinett Steven M
Celecoxib modulates the capacity for prostaglandin E2 and interleukin-10 production in alveolar macrophages from active smokers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(16 Pt 1):5835-41.
-
2003: Hillinger Sven; Yang Seok-Chul; Zhu Li; Huang Min; Duckett Russell; Atianzar Kimberly; Batra Raj K; Strieter Robert M; Dubinett Steven M; Sharma Sherven
EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer model.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(12):6457-65.
-
2003: Riedl Karen; Baratelli Felicita; Batra Raj K; Yang Seok Chul; Luo Jie; Escuadro Brian; Figlin Robert; Strieter Robert; Sharma Sherven; Dubinett Steven
Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells.
Molecular cancer 2003;2():35.
-
2003: Sharma Sherven; Batra Raj K; Yang Seok Chul; Hillinger Sven; Zhu Li; Atianzar Kimberly; Strieter Robert M; Riedl Karen; Huang Min; Dubinett Steven M
Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
Human gene therapy 2003;14(16):1511-24.
-
2003: Gardner Brian; Zhu Li X; Sharma Sherven; Tashkin Donald P; Dubinett Steven M
Methanandamide increases COX-2 expression and tumor growth in murine lung cancer.
The FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(14):2157-9.
-
2003: Zhang Ling; Sharma Sherven; Zhu Li X; Kogai Takahiko; Hershman Jerome M; Brent Gregory A; Dubinett Steven M; Huang Min
Nonradioactive iodide effectively induces apoptosis in genetically modified lung cancer cells.
Cancer research 2003;63(16):5065-72.
-
2003: Sharma Sherven; Yang Seok-Chul; Hillinger Sven; Zhu Li X; Huang Min; Batra Raj K; Lin Jeff F; Burdick Marie D; Strieter Robert M; Dubinett Steven M
SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10.
Molecular cancer 2003;2():22.
-
2003: Zhu Li X; Sharma Sherven; Gardner Brian; Escuadro Brian; Atianzar Kimberly; Tashkin Donald P; Dubinett Steven M
IL-10 mediates sigma 1 receptor-dependent suppression of antitumor immunity.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(7):3585-91.
-
2003: Sharma Sherven; Stolina Marina; Yang Seok-Chul; Baratelli Felicita; Lin Jeff F; Atianzar Kimberly; Luo Jie; Zhu Li; Lin Ying; Huang Min; Dohadwala Mariam; Batra Raj K; Dubinett Steven M
Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):961-8.
-
2003: Heuze-Vourc'h Nathalie; Zhu Li; Krysan Kostyantyn; Batra Raj K; Sharma Sherven; Dubinett Steven M
Abnormal interleukin 10Ralpha expression contributes to the maintenance of elevated cyclooxygenase-2 in non-small cell lung cancer cells.
Cancer research 2003;63(4):766-70.
-
2003: Batra Raj K; Lin Ying; Sharma Sherven; Dohadwala Mariam; Luo Jie; Pold Mehis; Dubinett Steven M
Non-small cell lung cancer-derived soluble mediators enhance apoptosis in activated T lymphocytes through an I kappa B kinase-dependent mechanism.
Cancer research 2003;63(3):642-6.
-
2003: Dubinett Steven M; Sharma Sherven; Huang Min; Dohadwala Mariam; Pold Mehis; Mao Jenny T
Cyclooxygenase-2 in lung cancer.
Progress in experimental tumor research. Fortschritte der experimentellen Tumorforschung. Progrès de la recherche expérimentale des tumeurs 2003;37():138-62.
-
2003: Sharma Sherven; Huang Min; Dohadwala Mariam; Pold Mehis; Batra Raj K; Dubinett Steven M
Cyclooxygenase 2-dependent regulation of antitumor immunity in lung cancer.
Methods in molecular medicine 2003;75():723-36.
-
2003: Sharma Sherven; Yang Seok Chul; Batra Raj K; Dubinett Steven M
Intratumoral therapy with cytokine gene-modified dendritic cells in murine lung cancer models.
Methods in molecular medicine 2003;75():711-22.
-
2002: Dohadwala Mariam; Batra Raj K; Luo Jie; Lin Ying; Krysan Kostyantyn; Pold Mehis; Sharma Sherven; Dubinett Steven M
Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion.
The Journal of biological chemistry 2002;277(52):50828-33.
-
2002: Tashkin Donald P; Baldwin Gayle C; Sarafian Theodore; Dubinett Steven; Roth Michael D
Respiratory and immunologic consequences of marijuana smoking.
Journal of clinical pharmacology 2002;42(11 Suppl):71S-81S.
-
2002: Bernal Ray M; Sharma Sherven; Gardner Brian K; Douglas Joanne T; Bergelson Jeffrey M; Dubinett Steven M; Batra Raj K
Soluble coxsackievirus adenovirus receptor is a putative inhibitor of adenoviral gene transfer in the tumor milieu.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(6):1915-23.
-
2002: Basak Saroj K; Harui Airi; Stolina Marina; Sharma Sherven; Mitani Kohnosuke; Dubinett Steven M; Roth Michael D
Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4.
Blood 2002;99(8):2869-79.
-
2002: Huang Min; Sharma Sherven; Zhu Li X; Keane Michael P; Luo Jie; Zhang Ling; Burdick Marie D; Lin Ying Q; Dohadwala Mariam; Gardner Brian; Batra Raj K; Strieter Robert M; Dubinett Steven M
IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis.
The Journal of clinical investigation 2002;109(7):931-7.
-
2002: Põld Mehis; Dohadwala M; Luo J; Lin Y; Dubinett S
Microarray identifies cyclo-oxygenase-2-dependent modulation of insulin-like growth factor binding protein-3 in non-small cell lung cancer cells.
Chest 2002;121(3 Suppl):29S-30S.
-
2002: Gardner Brian; Zu Li X; Sharma Sherven; Liu Qian; Makriyannis Alexandros; Tashkin Donald P; Dubinett Steven M
Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-beta.
Biochemical and biophysical research communications 2002;290(1):91-6.
-
2001: Sharma S; Stolina M; Zhu L; Lin Y; Batra R; Huang M; Strieter R; Dubinett S M
Secondary lymphoid organ chemokine reduces pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma.
Cancer research 2001;61(17):6406-12.
-
2001: Huang M; Batra R K; Kogai T; Lin Y Q; Hershman J M; Lichtenstein A; Sharma S; Zhu L X; Brent G A; Dubinett S M
Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer.
Cancer gene therapy 2001;8(8):612-8.
-
2001: Dohadwala M; Luo J; Zhu L; Lin Y; Dougherty G J; Sharma S; Huang M; Pold M; Batra R K; Dubinett S M
Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44.
The Journal of biological chemistry 2001;276(24):20809-12.
-
2000: Zhu L X; Sharma S; Stolina M; Gardner B; Roth M D; Tashkin D P; Dubinett S M
Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(1):373-80.
-
2000: Batra R K; Dubinett S M; Henkle B W; Sharma S; Gardner B K
Adenoviral gene transfer is inhibited by soluble factors in malignant pleural effusions.
American journal of respiratory cell and molecular biology 2000;22(5):613-9.
-
2000: Dubinett S M; Batra R K; Miller P W; Sharma S
Tumor antigens in thoracic malignancy.
American journal of respiratory cell and molecular biology 2000;22(5):524-7.
-
2000: Sharma S; Stolina M; Luo J; Strieter R M; Burdick M; Zhu L X; Batra R K; Dubinett S M
Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(9):4558-63.
-
2000: Kiertscher S M; Luo J; Dubinett S M; Roth M D
Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(3):1269-76.
-
2000: Miller P W; Sharma S; Stolina M; Butterfield L H; Luo J; Lin Y; Dohadwala M; Batra R K; Wu L; Economou J S; Dubinett S M
Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication.
Human gene therapy 2000;11(1):53-65.
-
2000: Stolina M; Sharma S; Lin Y; Dohadwala M; Gardner B; Luo J; Zhu L; Kronenberg M; Miller P W; Portanova J; Lee J C; Dubinett S M
Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(1):361-70.
-
1999: Sharma S; Stolina M; Lin Y; Gardner B; Miller P W; Kronenberg M; Dubinett S M
T cell-derived IL-10 promotes lung cancer growth by suppressing both T cell and APC function.
Journal of immunology (Baltimore, Md. : 1950) 1999;163(9):5020-8.
-
1998: Miller P W; Sharma S; Stolina M; Chen K; Zhu L; Paul R W; Dubinett S M
Dendritic cells augment granulocyte-macrophage colony-stimulating factor (GM-CSF)/herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer.
Cancer gene therapy 1998;5(6):380-9.
-
1998: Smith R M; Dubinett S M; Grudko K; Rosenow E C; Budman D R; Schnader J
Clinical conference on management dilemmas: a young woman with a 10-cm chest mass.
Chest 1998;114(1):295-306.
-
1998: Huang M; Stolina M; Sharma S; Mao J T; Zhu L; Miller P W; Wollman J; Herschman H; Dubinett S M
Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.
Cancer research 1998;58(6):1208-16.
-
1998: Schneider S C; Deng H K; Rottinger B; Sharma S; Stolina M; Bonpane C; Miller A; Dubinett S; Kyewski B; Sercarz E
Tolerance and determinant hierarchy.
Novartis Foundation symposium 1998;215():54-66; discussion 66-72.
-
1997: Sharma S; Miller P W; Stolina M; Zhu L; Huang M; Paul R W; Dubinett S M
Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cells.
Gene therapy 1997;4(12):1361-70.
-
1997: Baldwin G C; Tashkin D P; Buckley D M; Park A N; Dubinett S M; Roth M D
Marijuana and cocaine impair alveolar macrophage function and cytokine production.
American journal of respiratory and critical care medicine 1997;156(5):1606-13.
-
1997: Mao J T; Zhu L X; Sharma S; Chen K; Huang M; Santiago S J; Gulsurd J; Tashkin D P; Dubinett S M
Cocaine inhibits human endothelial cell IL-8 production: the role of transforming growth factor-beta.
Cellular immunology 1997;181(1):38-43.
-
1997: Tashkin D P; Roth M D; Dubinett S M
Medicinal marijuana?
The New England journal of medicine 1997;336(16):1186; author reply 1186-7.
-
1997: Arthur J F; Butterfield L H; Roth M D; Bui L A; Kiertscher S M; Lau R; Dubinett S; Glaspy J; McBride W H; Economou J S
A comparison of gene transfer methods in human dendritic cells.
Cancer gene therapy 1997;4(1):17-25.
-
1996: Huang M; Sharma S; Mao J T; Dubinett S M
Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production.
Journal of immunology (Baltimore, Md. : 1950) 1996;157(12):5512-20.
-
1996: Mao J T; Huang M; Wang J; Sharma S; Tashkin D P; Dubinett S M
Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-gamma production.
Cellular immunology 1996;172(2):217-23.
-
1996: Sharma S; Wang J; Huang M; Paul R W; Lee P; McBride W H; Economou J S; Roth M D; Kiertscher S M; Dubinett S M
Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity.
Cancer gene therapy 1996;3(5):302-13.
-
1996: Wang J; Huang M; Lee P; Komanduri K; Sharma S; Chen G; Dubinett S M
Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1996;16(1):53-60.
-
1995: Huang M; Wang J; Lee P; Sharma S; Mao J T; Meissner H; Uyemura K; Modlin R; Wollman J; Dubinett S M
Human non-small cell lung cancer cells express a type 2 cytokine pattern.
Cancer research 1995;55(17):3847-53.
-
1995: Kim J; Modlin R L; Moy R L; Dubinett S M; McHugh T; Nickoloff B J; Uyemura K
IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(4):2240-7.
-
1995: Dubinett S M; Huang M; Dhanani S; Economou J S; Wang J; Lee P; Sharma S; Dougherty G J; McBride W H
Down-regulation of murine fibrosarcoma transforming growth factor-beta 1 expression by interleukin 7.
Journal of the National Cancer Institute 1995;87(8):593-7.
-
1994: Dubinett S M; Huang M; Lichtenstein A; McBride W H; Wang J; Markovitz G; Kelley D; Grody W W; Mintz L E; Dhanani S
Tumor necrosis factor-alpha plays a central role in interleukin-2-induced pulmonary vascular leak and lymphocyte accumulation.
Cellular immunology 1994;157(1):170-80.
-
1994: Dhanani S; Huang M; Wang J; Dubinett S M
Interferon-alpha inhibits murine macrophage transforming growth factor-beta mRNA expression.
Inflammation 1994;18(3):301-9.
-
1994: Kelley D M; Lichtenstein A; Wang J; Taylor A N; Dubinett S M
Corticotropin-releasing factor reduces lipopolysaccharide-induced pulmonary vascular leak.
Immunopharmacology and immunotoxicology 1994;16(2):139-48.
-
1993: Miller A R; McBride W H; Dubinett S M; Dougherty G J; Thacker J D; Shau H; Kohn D B; Moen R C; Walker M J; Chiu R
Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2.
Blood 1993;82(12):3686-94.
-
1993: Dubinett S M; Huang M; Dhanani S; Wang J; Beroiza T
Down-regulation of macrophage transforming growth factor-beta messenger RNA expression by IL-7.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(12):6670-80.
-
1993: Dubinett S M; Kradin R L
Cytokine immunotherapy of non-small cell lung cancer.
Regional immunology 1993;5(3-4):232-43.
-
1993: Dubinett S M; Patrone L; Huang M; Markowitz J; McBride W H; Economou J S; Tobias J; Kelley D; Yan D; Seelig M
Interleukin-2-responsive wound-infiltrating lymphocytes in surgical adjuvant cancer immunotherapy.
Immunological investigations 1993;22(1):13-23.
-
1993: Dubinett S M; Huang M; Dhanani S; Kelley D; Lichtenstein A; Grody W W; Mintz L E
In situ regulation of pulmonary macrophage TNF-alpha mRNA expression by IL2.
Chest 1993;103(2 Suppl):91S-94S.
-
1993: Nguyen Q H; Moy R L; Roth M D; Yamamoto R; Tomono S; Dubinett S M
Expression of CD45 isoforms in fresh and IL-2-cultured tumor-infiltrating lymphocytes from basal cell carcinoma.
Cellular immunology 1993;146(2):421-30.
-
1993: Dubinett S M; Patrone L; Tobias J; Cochran A J; Wen D R; McBride W H
Intratumoral interleukin-2 immunotherapy: activation of tumor-infiltrating and splenic lymphocytes in vivo.
Cancer immunology, immunotherapy : CII 1993;36(3):156-62.
-
1992: McDonagh J; Fossel E T; Kradin R L; Dubinett S M; Laposata M; Hallaq Y A
Effects of tumor necrosis factor-alpha on peroxidation of plasma lipoprotein lipids in experimental animals and patients.
Blood 1992;80(12):3217-26.
-
1992: McBride W H; Thacker J D; Comora S; Economou J S; Kelley D; Hogge D; Dubinett S M; Dougherty G J
Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity.
Cancer research 1992;52(14):3931-7.
-
1991: Dubinett S M; Callahan R J; Xia W J; Ahmad M; Strauss H W; Kradin R L
Cytokine administration alters the distribution of activated lymphocytes to the lung.
Pathobiology : journal of immunopathology, molecular and cellular biology 1991;59(6):372-7.
-
1989: Dubinett S M; Kurnick J T; Kradin R L
Adoptive immunotherapy of murine pulmonary metastases with interleukin 2 and interferon-gamma.
American journal of respiratory cell and molecular biology 1989;1(5):361-9.
-
1989: Gallagher W J; Dubinett S M; Hoover H C; Kradin R L
Efficacy of adjuvant interleukin-2 after excision of BALB/c fibrosarcomas.
Surgery 1989;106(2):120-5.
-
1989: Kradin R L; Kurnick J T; Lazarus D S; Preffer F I; Dubinett S M; Pinto C E; Gifford J; Davidson E; Grove B; Callahan R J
Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer.
Lancet 1989;1(8638):577-80.
-
1989: Kradin R L; Kurnick J T; Preffer F I; Dubinett S M; Dickersin G R; Pinto C
Adoptive immunotherapy with IL-2 results in the loss of delayed-type hypersensitivity responses and the development of immediate hypersensitivity to recall antigens.
Clinical immunology and immunopathology 1989;50(2):184-95.
-
1988: Kradin R; Dubinett S; Mullin J; Boyle L; Strauss H W; Bourgoin P M; Preffer F I; Kurnick J
Treatment of patients with advanced cancer using tumor-infiltrating lymphocytes and interleukin 2.
Transplantation proceedings 1988;20(2):336-8.
-
1987: Kradin R L; Boyle L A; Preffer F I; Callahan R J; Barlai-Kovach M; Strauss H W; Dubinett S; Kurnick J T
Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer.
Cancer immunology, immunotherapy : CII 1987;24(1):76-85.
Sign-in to see more